Qkine launches cell therapy grade recombinant proteins to support next-generation therapies
Qkine, Ltd., a specialist bioactive protein manufacturer with its core technology developed at the University of Cambridge, today announced the launch of its Cell Therapy Grade proteins, engineered to support the stringent requirements of cell therapy research, process development, and GMP manufacturing.
Priory and Psyomics shortlisted for national award recognising digital innovation in mental health care
Priory, the UK’s largest independent provider of mental health and adult social care services, has been shortlisted for a prestigious national award for its collaboration with Psyomics, a leading provider of digital mental health technology.
Cambridge animal woundcare spinout NoBACZ lands £5m injection
A company founded by two Cambridge academics who aim to tackle a perennial problem in veterinary treatments for farm animals has secured £4.8m in funding from a group of investors, Sky News understands.
Just a matter of time as Forefront RF eyes Asian smartwatch markets
Forefront RF, a Cambridge-based fabless semiconductor scale-up whose technology supports the next generation of wireless communications, is set to expand into the fast-growing smartwatch markets of India, China and South Korea. To facilitate this, it has enlisted the support of international business development consultancy Intralink.
Atelerix signs agreement with CliniSciences to broaden access to cryo-free preservation solutions across Europe and North Africa
Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has entered into a new distribution agreement with CliniSciences, a leading European player in the distribution and development of solutions for research and diagnostics.
Healx AI alliance with US-based Vuja De Sciences targets killer cancer recurrence
Healx in Cambridge and New Jersey-based Vuja De Sciences have formed a powerful alliance focused on addressing cancer recurrence and metastatic endurance.
Abselion introduces Protein G Total Antibody Quantification Kit
Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced the launch of its Protein G Total Antibody Quantification Kit.
Closed Loop Medicine launches digital GLP-1 dosing platform
UK medtech firm Closed Loop Medicine has launched its first product in the US, a digital tool for personalising the dose of GLP-1 agonist-based weight loss therapies.
Amcor and Greenback trial chemical recycling for flexible plastics
Amcor and Greenback Recycling Technologies have launched a six-month recycling trial of Greenback’s Enval pyrolysis technology at the Heanor site in Derbyshire.
Wild Hydrogen wins Innovate UK Smart Grant
Innovate UK Smart Grant £350,000 to advance a carbon-negative hydrogen pilot plant
Lacuna deploys more Oxford Space Systems helical antennas for IoT
Oxford Space Systems (OSS) and Lacuna Space have announced the successful deployment of an additional two OSS helical antennas.
Abselion Launches AAVX and AAV9 Total Capsid Quantification Kits
Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its product offering, with the launch of the AAVX Total Capsid Quantification Kit and the AAV9 Total Capsid Quantification Kit.
NATO backs 52North tech for nuclear emergency preparedness programme
A University of Cambridge spin-out whose product can be used to treat radiation sickness following a nuclear attack, has secured further recognition with NATO. Based locally at the Hauser Forum, 52North has been recognised for a second time by the North Atlantic Treaty Organization, which is headquartered in Belgium.
Atelerix and Rodon Global partner to integrate cryo-free preservation technology into specialist logistics solutions
Initial agreement to incorporate Atelerix’s non-cryogenic cell preservation technology into international freight and logistics services for drug discovery and clinical trials
Qureight appoints Craig Rhodes as Head of Partnerships to lead on pharma relationship management
Appointment underscores Qureight’s commitment to drive adoption of its AI-powered imaging and clinical data curation platform to support clinical trials and accelerate drug development timelines for lung and heart diseases.
Paragraf closes $55M Series C funding round
Paragraf pioneers graphene-based electronics with standard semiconductor processes, producing magnetic sensors and GMS while developing advanced devices.
Monument Therapeutics to trial schizophrenia therapy in partnership with FNIH
The trial is a component of the Accelerating Medicines Partnership Schizophrenia programme, managed by FNIH.
Forefront RF makes leadership changes for next stage of global growth
Dynamic tech duo Rupert Baines and former chair Phil O'Donovan have been unveiled as a new executive leadership team to spearhead a fresh push for global growth by Cambridge fabless semiconductor company Forefront RF.
Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion
Industry-leaders Sunil Shah (CEO, o2h Ventures) and Dr Catherine Elton (CBO, Axol Bioscience) appointed as Chair and Non-Executive Director, respectively
Thought Machine supports Zopa Bank to launch Biscuit
Thought Machine, a cloud-native banking technology company, has partnered with Zopa Bank to launch its current bank account Biscuit.